# FDA Inspection 1230851 - Lianyungang Runzhong Pharmaceutical Co., Ltd. - January 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/lianyungang-runzhong-pharmaceutical-co-ltd/4291f256-b2a9-4329-a432-ca489dd837f4
Source feed: FDA_Inspections

> FDA Inspection 1230851 for Lianyungang Runzhong Pharmaceutical Co., Ltd. on January 26, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230851
- Company Name: Lianyungang Runzhong Pharmaceutical Co., Ltd.
- Inspection Date: 2024-01-26
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1073786 - 2018-10-26](https://www.keypedia.com/records/fda_inspections/lianyungang-runzhong-pharmaceutical-co-ltd/6cc89dd5-deb9-4326-923b-6077c937e1f9)
- [FDA Inspection 873844 - 2014-03-27](https://www.keypedia.com/records/fda_inspections/lianyungang-runzhong-pharmaceutical-co-ltd/1586ea89-c380-420b-894f-12f7fd9f3817)
- [FDA Inspection 738641 - 2011-07-28](https://www.keypedia.com/records/fda_inspections/lianyungang-runzhong-pharmaceutical-co-ltd/5666b439-3001-4032-b1b0-a3cf7ddd254d)

Company: https://www.keypedia.com/companies/lianyungang-runzhong-pharmaceutical-co-ltd/f8c39880-c70f-450b-a735-e3cd658f394e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c